Women’s Health Startups Graduate from PharmStars Digital Health Accelerator
A new cohort of startups has graduated from PharmStars, a digital health accelerator. This latest group focused on women’s health and health equity.
Don’t miss the MedCity INVEST PharmaTech virtual conference July 26
The conference highlights the convergence of digital health and drug development. Among the panel discussions are a focus on the state of AI in drug discovery and the future of digital medicines. A startup pitch contest spotlights companies seeking to improve clinical trials. Register for free today!
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Neuro startups form latest group of grads from PharmStars digital health accelerator
PharmStars, a digital health accelerator, graduated its latest cohort of startups, each of them developing a solution addressing some aspect of neurological disease. The accelerator is accepting applications for the next group of startups for the fall program. The theme is innovations in real-world evidence.
Creating better alignment between digital and pharma sectors
At the MedCity INVEST PharmaTech virtual conference July 26, strategies and alignment between digital and pharma companies will be a major theme of the conference. Register now to join the conversation.
INVEST PharmaTech: The convergence of digital health and biopharma
MedCity INVEST PharmaTech, a virtual conference scheduled for July 26, will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how to adopt digital strategies to transform every aspect of the pharma industry.
First cohort of digital health startups graduates from PharmStars accelerator
PharmStars, an accelerator for companies developing digital solutions for pharmaceutical companies, has graduated its first class of startups. The theme for this initial group was “innovation in clinical trials.”
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.